Log in to your Inderes Free account to see all free content on this page.

Lipigon Pharmaceuticals

0.00 SEK

-13.79%

Less than 1K followers

LPGO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lipigon Pharmaceuticals

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue1.310.3
EBITDA-6.7-11.1-25.5-9.1-8.5-7.4-7.2-32.1
EBIT-6.7-11.1-25.6-9.1-8.5-7.4-7.2-32.2
EBIT-%-840.2 %-248.6 %
Profit before taxes-6.7-10.7-25.3-9.2-8.7-7.4-7.2-32.4
Net income-6.7-10.7-25.3-9.2-8.7-7.4-7.2-32.4
Login required

This content is only available for logged in users